|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C12P 19/34 | |||
| C12N 15/63 | |||
| C12N 15/88 | |||
| C07H 21/02 | |||
| C07H 21/04 | |||
| A01N 43/04 |
| (11) | Patento numeris | 1799859 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05798891.7 |
| Europos patento paraiškos padavimo data | 2005-09-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/033837 |
| Data | 2005-09-19 |
| (87) | Numeris | WO 2006/034348 |
| Data | 2006-03-30 |
| (30) | Numeris | Data | Šalis |
| 611100 P | 2004-09-17 | US | |
| 663442 P | 2005-03-18 | US |
| (72) |
MONIA, Brett, P., US
SIWKOWSKI, Andrew, M., US
BHANOT, Sanjay, US
|
| (73) |
Isis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | ENHANCED ANTISENSE OLIGONUCLEOTIDES |
| ENHANCED ANTISENSE OLIGONUCLEOTIDES |